Pozo-Rosich, P., Samaan, K. H., Schwedt, T. J., Nicholson, R. A., Rettiganti, M., & Pearlman, E. M. (2021). Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis. Advances in therapy, 38(6), 3154-3165. https://doi.org/10.1007/s12325-021-01708-8
Chicago Style (17th ed.) CitationPozo-Rosich, Patricia, Karen H. Samaan, Todd J. Schwedt, Robert A. Nicholson, Mallikarjuna Rettiganti, and Eric M. Pearlman. "Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis." Advances in Therapy 38, no. 6 (2021): 3154-3165. https://doi.org/10.1007/s12325-021-01708-8.
MLA (9th ed.) CitationPozo-Rosich, Patricia, et al. "Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis." Advances in Therapy, vol. 38, no. 6, 2021, pp. 3154-3165, https://doi.org/10.1007/s12325-021-01708-8.